Cargando…

Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome

Background: Tyrosinaemia type 1 is a rare inherited metabolic disease caused by an enzyme defect in the tyrosine degradation pathway. It is treated using nitisinone and a low-protein diet. In a workshop in 2013, a group of nutritional specialists from Germany, Switzerland and Austria agreed to advoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bärhold, Friederike, Meyer, Uta, Neugebauer, Anne-Kathrin, Thimm, Eva Maria, Lier, Dinah, Rosenbaum-Fabian, Stefanie, Och, Ulrike, Fekete, Anna, Möslinger, Dorothea, Rohde, Carmen, Beblo, Skadi, Hochuli, Michel, Bogovic, Nina, Korpel, Vanessa, vom Dahl, Stephan, Mayorandan, Sebene, Fischer, Aleksandra, Freisinger, Peter, Dokoupil, Katharina, Heddrich-Ellerbrok, Margret, Jörg-Streller, Monika, van Teeffelen-Heithoff, Agnes, Lahl, Janina, Das, Anibh Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824011/
https://www.ncbi.nlm.nih.gov/pubmed/33396520
http://dx.doi.org/10.3390/nu13010134
_version_ 1783639973269864448
author Bärhold, Friederike
Meyer, Uta
Neugebauer, Anne-Kathrin
Thimm, Eva Maria
Lier, Dinah
Rosenbaum-Fabian, Stefanie
Och, Ulrike
Fekete, Anna
Möslinger, Dorothea
Rohde, Carmen
Beblo, Skadi
Hochuli, Michel
Bogovic, Nina
Korpel, Vanessa
vom Dahl, Stephan
Mayorandan, Sebene
Fischer, Aleksandra
Freisinger, Peter
Dokoupil, Katharina
Heddrich-Ellerbrok, Margret
Jörg-Streller, Monika
van Teeffelen-Heithoff, Agnes
Lahl, Janina
Das, Anibh Martin
author_facet Bärhold, Friederike
Meyer, Uta
Neugebauer, Anne-Kathrin
Thimm, Eva Maria
Lier, Dinah
Rosenbaum-Fabian, Stefanie
Och, Ulrike
Fekete, Anna
Möslinger, Dorothea
Rohde, Carmen
Beblo, Skadi
Hochuli, Michel
Bogovic, Nina
Korpel, Vanessa
vom Dahl, Stephan
Mayorandan, Sebene
Fischer, Aleksandra
Freisinger, Peter
Dokoupil, Katharina
Heddrich-Ellerbrok, Margret
Jörg-Streller, Monika
van Teeffelen-Heithoff, Agnes
Lahl, Janina
Das, Anibh Martin
author_sort Bärhold, Friederike
collection PubMed
description Background: Tyrosinaemia type 1 is a rare inherited metabolic disease caused by an enzyme defect in the tyrosine degradation pathway. It is treated using nitisinone and a low-protein diet. In a workshop in 2013, a group of nutritional specialists from Germany, Switzerland and Austria agreed to advocate a simplified low-protein diet and to allow more natural protein intake in patients with tyrosinaemia type 1. This retrospective study evaluates the recommendations made at different treatment centers and their impact on clinical symptoms and metabolic control. Methods: For this multicenter study, questionnaires were sent to nine participating treatment centers to collect data on the general therapeutic approach and data of 47 individual patients treated by those centers. Results: Dietary simplification allocating food to 3 categories led to increased tyrosine and phenylalanine blood concentrations without weighing food. Phenylalanine levels were significantly higher in comparison to a strict dietary regimen whereas tyrosine levels in plasma did not change. Non-inferiority was shown for the simplification and liberalization of the diet. Compliance with dietary recommendations was higher using the simplified diet in comparison to the stricter approach. Age correlates negatively with compliance. Conclusions: Simplification of the diet with increased natural protein intake based on three categories of food may be implemented in the diet of patients with tyrosinaemia type 1 without significantly altering metabolic control. Patient compliance is strongly influencing tyrosine blood concentrations. A subsequent prospective study with a larger sample size is necessary to get a better insight into the effect of dietary recommendations on metabolic control.
format Online
Article
Text
id pubmed-7824011
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78240112021-01-24 Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome Bärhold, Friederike Meyer, Uta Neugebauer, Anne-Kathrin Thimm, Eva Maria Lier, Dinah Rosenbaum-Fabian, Stefanie Och, Ulrike Fekete, Anna Möslinger, Dorothea Rohde, Carmen Beblo, Skadi Hochuli, Michel Bogovic, Nina Korpel, Vanessa vom Dahl, Stephan Mayorandan, Sebene Fischer, Aleksandra Freisinger, Peter Dokoupil, Katharina Heddrich-Ellerbrok, Margret Jörg-Streller, Monika van Teeffelen-Heithoff, Agnes Lahl, Janina Das, Anibh Martin Nutrients Article Background: Tyrosinaemia type 1 is a rare inherited metabolic disease caused by an enzyme defect in the tyrosine degradation pathway. It is treated using nitisinone and a low-protein diet. In a workshop in 2013, a group of nutritional specialists from Germany, Switzerland and Austria agreed to advocate a simplified low-protein diet and to allow more natural protein intake in patients with tyrosinaemia type 1. This retrospective study evaluates the recommendations made at different treatment centers and their impact on clinical symptoms and metabolic control. Methods: For this multicenter study, questionnaires were sent to nine participating treatment centers to collect data on the general therapeutic approach and data of 47 individual patients treated by those centers. Results: Dietary simplification allocating food to 3 categories led to increased tyrosine and phenylalanine blood concentrations without weighing food. Phenylalanine levels were significantly higher in comparison to a strict dietary regimen whereas tyrosine levels in plasma did not change. Non-inferiority was shown for the simplification and liberalization of the diet. Compliance with dietary recommendations was higher using the simplified diet in comparison to the stricter approach. Age correlates negatively with compliance. Conclusions: Simplification of the diet with increased natural protein intake based on three categories of food may be implemented in the diet of patients with tyrosinaemia type 1 without significantly altering metabolic control. Patient compliance is strongly influencing tyrosine blood concentrations. A subsequent prospective study with a larger sample size is necessary to get a better insight into the effect of dietary recommendations on metabolic control. MDPI 2020-12-31 /pmc/articles/PMC7824011/ /pubmed/33396520 http://dx.doi.org/10.3390/nu13010134 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bärhold, Friederike
Meyer, Uta
Neugebauer, Anne-Kathrin
Thimm, Eva Maria
Lier, Dinah
Rosenbaum-Fabian, Stefanie
Och, Ulrike
Fekete, Anna
Möslinger, Dorothea
Rohde, Carmen
Beblo, Skadi
Hochuli, Michel
Bogovic, Nina
Korpel, Vanessa
vom Dahl, Stephan
Mayorandan, Sebene
Fischer, Aleksandra
Freisinger, Peter
Dokoupil, Katharina
Heddrich-Ellerbrok, Margret
Jörg-Streller, Monika
van Teeffelen-Heithoff, Agnes
Lahl, Janina
Das, Anibh Martin
Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
title Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
title_full Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
title_fullStr Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
title_full_unstemmed Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
title_short Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
title_sort hepatorenal tyrosinaemia: impact of a simplified diet on metabolic control and clinical outcome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824011/
https://www.ncbi.nlm.nih.gov/pubmed/33396520
http://dx.doi.org/10.3390/nu13010134
work_keys_str_mv AT barholdfriederike hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT meyeruta hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT neugebauerannekathrin hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT thimmevamaria hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT lierdinah hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT rosenbaumfabianstefanie hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT ochulrike hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT feketeanna hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT moslingerdorothea hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT rohdecarmen hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT bebloskadi hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT hochulimichel hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT bogovicnina hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT korpelvanessa hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT vomdahlstephan hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT mayorandansebene hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT fischeraleksandra hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT freisingerpeter hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT dokoupilkatharina hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT heddrichellerbrokmargret hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT jorgstrellermonika hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT vanteeffelenheithoffagnes hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT lahljanina hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome
AT dasanibhmartin hepatorenaltyrosinaemiaimpactofasimplifieddietonmetaboliccontrolandclinicaloutcome